CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-04 | Christmas Patrick J. SVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +11,100 | 11,100 | ||
| 2017-01-04 | Ali Faraz Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +25,200 | 25,200 | ||
| 2017-01-04 | Mills Kenneth T. President and CEO | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2017-01-04 | Yoo Stephen Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2017-01-04 | Simpson Curran SVP, Technical Operations | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2017-01-04 | Vasista Vittal Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2016-12-31 | Vasista Vittal Chief Financial Officer | Grant or award | +1,372 | $6.79 | $9K | 116,812 |
| 2016-12-08 | Simpson Curran SVP, Technical Operations | Grant or award | +39,500 | 39,500 | ||
| 2016-08-18 | Christmas Patrick J. Senior VP, General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2016-08-15 | Tasse Daniel Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-08-05 | Abdun-Nabi Daniel Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-06-13 | Mills Kenneth T. President and CEO | Exercise or conversion | +125,000 | $0.85 | $106K | 140,440 |
| 2016-06-13 | Mills Kenneth T. President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −125,000 | 583,200 | ||
| 2016-06-01 | STUMP DAVID C Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2016-06-01 | KARABELAS ARGERIS N Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2016-06-01 | BESHAR LUKE M Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2016-06-01 | Samuels Camille D Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2016-06-01 | HAYDEN DONALD J JR Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2016-06-01 | Fox Allan M. Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2016-05-17 | FMR LLC | Sale | −18,300 | $12.41 | $227K | 619,376 |
Page 49 of 56 · 1,104 trades